NIH-funded research NIH-funded research

APOE4 and inflammation effects on breathing control health outcomes

Official title: Rest/Active Phase Specificity of APOE4 and Inflammation on Respiratory Plasticity

Funded at University of Florida · NIH-11552975 · Data updated 2026-11-12

This project studies how a common genetic factor (APOE4) and inflammation affect a key form of breathing plasticity that could influence breathing in people with spinal cord injury or ALS.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 1, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$249,000
NIH project number4R00HL175029-03
Project IDNIH-11552975 on NIH RePORTER

Who could benefit from this research

Could help

Patients with spinal cord injury or ALS who are undergoing breathing rehabilitation could benefit from advances in this research.

Less likely to help

The study focuses on mechanisms and may not directly provide immediate treatment for all patients.

What this research studies

If you have a condition affecting breathing, this project looks at why certain genetic factors and inflammation change how the nerves controlling breathing adapt after low oxygen events. Researchers will use a well-established model of breathing plasticity to see how APOE alleles and inflammation alter the protective brain-spinal pathways involved in breathing. The goal is to identify molecular targets that could make breathing therapies more effective for people with spinal cord injury or amyotrophic lateral sclerosis. The work builds on prior findings showing APOE4 can undermine respiratory plasticity through adenosine signaling. Results could inform personalized approaches to improve breathing rehabilitation.

Why it matters

Potential benefit: If successful, the work could lead to more effective, tailored breathing therapies for patients with spinal cord injury or ALS.

How similar studies have gone: Previous work indicates APOE4 can alter respiratory plasticity; this study extends those findings to identify actionable targets.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Marciante, Alexandria — University of Florida
  • Study coordinator: Marciante, Alexandria

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.